König et al. 3 infected siRNA-transfected cells with a recombinant influenza A/WSN/33 (WSN) virus in which the coding region of hemagglutinin was replaced by a luciferase reporter gene.

Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

Prabakaran M and Kwang J. Recombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccine. Bioengineered 2014; 5(1): 45–48. 2. Prabakaran M, ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus could mutate and become more transmissible.

ASPR's National Pre-Pandemic Influenza ... recombinant vaccine for use in the event of a pandemic." That would allow the company "to leverage the technology used for one of our approved seasonal ...

Recombinant MPXV A35R protein, which is similar to Vaccinia virus A33R protein, has been created by Sino Biological. A33R protein from the Vaccinia virus is a homolog of MPXV A35R protein.